Categories: DiagnosticsFutureHealthTechResearchTechnology
Founded in 2021 and headquartered in Woburn, Massachusetts, Spear Bio is dedicated to its mission of revolutionizing biomarker research and diagnostics through innovation and accessibility. Leveraging its unique homogeneous assay format, SPEAR technology consistently delivers highly sensitive and precise protein measurements. Spear Bio envisions a future where high-performance assays democratize access to critical insights, accelerating progress in research and medicine worldwide.
Investors 1
Funding Rounds 1
| Date | Series | Amount | Investors |
| 12.08.2024 | Series A | $45M | - |
Mentions in press and media 6
| Date | Title | Description |
| 12.08.2024 | Spear Bio: $45 Million (Series A) Raised To Advance Protein Research And Disease Diagnostics | Spear Bio (a biotechnology company enabling the measurement of protein molecules down to dozens of copies with ubiquitous qPCR equipment) announced the closing of its $45 million Series A financing. This oversubscribed round was co-led by F... |
| 29.07.2024 | Spear Bio Raises $45M in Series A Financing | Spear Bio Inc., a Woburn, MA-based biotechnology company enabling the measurement of protein molecules down to dozens of copies with ubiquitous qPCR equipment, closed a $45m Series A financing.
The round was co-led by Foresite Capital and B... |
| 29.07.2024 | Spear Bio Inks $45M in Oversubscribed Series A |
WOBURN, MA, Spear Bio, a biotechnology company enabling the measurement of protein molecules, announced the closing of its $45 million Series A financing.
>> Click here for more funding data on Spear Bio
>> To export Spear Bio ... |
| 30.11.2023 | Spear Bio Closes Seed Funding of Tens of Millions of US Dollars | Spear Bio Assay Kit
Spear Bio, a Woburn, MA-based Harvard University biotech spin-off developing scalable solutions for ultrasensitive detection of protein biomarkers, raised tens of millions of US dollars in Seed funding.
The round was led... |
| 15.11.2023 | Deals in brief: Augmentus and Etaily secure Series A funding, SC Ventures launches Libeara, multiple China and India deals, and more | Augmentus secures USD 5 million in Series A round
The Singapore-based no-code robotics software company has secured USD 5 million in a Series A funding round led by Sierra Ventures, along with participation from existing seed investor Cocoo... |
| - | Spear Bio | “Spear Bio enables laboratories to perform ultrasensitive immunoassays on microsamples at scale.” |
Reviews 0
